Novartis Ag (NVS) Current Taxes (2009 - 2026)

Novartis Ag has disclosed Current Taxes across 18 years of filings, most recently posting $2.3 billion for Q2 2026.

• In Q2 2026, Current Taxes fell 18.19% year-over-year to $2.3 billion; the TTM figure through Jun 2026 stood at $2.3 billion (down 18.19% YoY), while the FY2025 annual figure was $2.0 billion, up 23.14% from the prior year.
• Current Taxes came in at $2.3 billion for Q2 2026 at Novartis Ag, up from $1.8 billion in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $3.3 billion in Q3 2025 to a low of $370.0 million in Q1 2023.
• Average Current Taxes over 5 years is $2.2 billion, with a median of $2.2 billion recorded in 2024.
• Year-over-year, Current Taxes sank 85.65% in 2023 and jumped 345.95% in 2024.
• Over 5 years, Current Taxes stood at $2.5 billion in 2022, then slipped by 25.27% to $1.9 billion in 2023, then dropped by 15.53% to $1.6 billion in 2024, then rose by 23.14% to $2.0 billion in 2025, then increased by 17.42% to $2.3 billion in 2026.
• Per Business Quant data, the three most recent Current Taxes figures were $2.3 billion in Q2 2026, $1.8 billion in Q1 2026, and $2.0 billion in Q4 2025.